- The Dana-Farber community is saddened by the death of Carolyn Mary Kaelin, MD, MPH, FACS, of Boston, MA, who died on July 28, surrounded by loved ones. A gifted and compassionate breast cancer surgeon, Dr. Kaelin was a surgical oncologist in the Women's Cancers Program at Dana-Farber and director of the Breast Clinic at Brigham and Women's Hospital.
- Study led by Dr. Alexi Wright finds intraperitoneal chemotherapy substantially improves survival of ovarian cancer patients, but that many women who could benefit are not receiving the treatment.
Tags: chemotherapy, OvarianCancer
- Dana-Farber/Brigham and Women's Cancer Center has been named the best for cancer care in New England for the 15th straight year and fourth overall in the country by U.S. News & World Report.
- Dana-Farber's David Weinstock, MD, and colleagues report that a novel compound stops B-cell acute lymphoblastic leukemia tumor cell growth in pre-clinical studies; approach may be effective in other cancers as well.
Tags: BasicResearch, Leukemia
- More than two-thirds of adolescents and young adults dying of cancer utilized one or more aggressive interventions in the last month of life, according to a retrospective study published in JAMA Oncology. The findings suggest the need for more research into whether patients have been adequately supported to contemplate their end-of-life options or whether the pattern reflects their well-considered wishes.
Tags: EndOfLife, PopulationScience
- The Department of Cancer Immunology and AIDS at Dana-Farber is changing its name to the Department of Cancer Immunology and Virology.
Tags: BasicResearch, Immunotherapy
- Before you fire up the backyard grill this summer, review these tips from Dana-Farber Cancer Institute experts to help reduce your exposure to potentially cancer causing chemicals.
Tags: Nutrition, Prevention
- Dana-Farber Cancer Institute and Eli Lilly and Company announced a multiyear collaboration to research new medicines under development to fight cancer.
Tags: BasicResearch, Partnerships
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center remains the nation's top pediatric cancer program, according to the 2015-16 edition of U.S. News & World Report's Best Children's Hospitals.
- Dana-Farber's Molecular Cancer Imaging Facility in Boston's Innovation District will use cutting edge technology for research on improving cancer diagnosis and developing precision drugs matched to individual patients.
Tags: BasicResearch, Imaging
Showing 1-10 of 611 items